Professor Bjoern Schelter
Personal Chair
- 51cg
-
- Email Address
- b.schelter@abdn.ac.uk
- Telephone Number
- +44 (0)1224 272520
- Office Address
- Institute for Complex Systems and Mathematical Biology (ICSMB) Room 341, Meston Building, Meston Walk King's College, Old Aberdeen 51cg Aberdeen AB24 3UE UK
- School/Department
- School of Natural and Computing Sciences
- Publications
-
Page 1 of 11 Results 1 to 10 of 102
Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer's disease explains unexpected phase 3 trial results
British Journal of Clinical Pharmacology, vol. 92, no. 8, pp. 2645-2656Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
- [ONLINE]
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data
The Journal of Prevention of Alzheimer's Disease, vol. 13, no. 6, 100560Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease
The Journal of Prevention of Alzheimer's Disease, vol. 13, no. 3, 100480Contributions to Journals: Articles- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
FDG-PET Image Classification in Alzheimer’s Disease: from Traditional Visual Analysis to Advanced Transfer Learning
Nuclear Medicine and Molecular Imaging, vol. 59, pp. 201-208Contributions to Journals: Articles- [ONLINE]
- [ONLINE] DOI:
Obtaining personalized predictions from a randomized controlled trial on Alzheimer’s disease
Scientific Reports, vol. 15, 1671Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Significant dose-dependent reduction in neurofilament light chain concentration in plasma with oral tau aggregation inhibitor hydromethylthionine mesylate
Alzheimer's Dementia, vol. 19, no. S24, e083153Contributions to Journals: Articles- [ONLINE] DOI:
Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
Journal of Prevention of Alzheimer's Disease, vol. 9, pp. 780-790Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Inferring the underlying multivariate structure from bivariate networks with highly correlated nodes
Scientific Reports, vol. 12, no. 1, 12486Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Crossed cerebellar diaschisis in Alzheimer's disease
Nuclear Medicine Communications, vol. 43, no. 4, pp. 423-427Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Determining Network Structure from Data: Nonlinear Modeling Methods
Chapters in Books, Reports and Conference Proceedings: Entries for Encyclopedias and Dictionaries- [ONLINE] DOI:
- [ONLINE]